Literature DB >> 32473817

Assessment of facility performance during mass treatment of chronic hepatitis C in Egypt: Enablers and obstacles.

Hend Ibrahim Shousha1, Mohamed Said2, Wafaa ElAkel2, Arwa ElShafei3, Gamal Esmat2, Emam Waked4, Manal Hamdy Elsayed5, Wahid Doss2, Maysa Elrazky6, Mai Mehrez7, Mohamed Hassany8, Dina Zeyada9, Mahmoud Anis9, Magdy Alserafy2.   

Abstract

BACKGROUND: The national committee for control of viral hepatitis (NCCVH) in Egypt, settled by the Ministry of health, treated over one million patients in around 60 centers with chronological changes in drug combinations. This research aims to study the health care facilities and services provided by NCCVH treatment centers in Egypt and explore hinders faced.
METHODS: A cross-sectional operational research study. Multistage random sampling technique was applied for Egyptian governorates. From each stratum one governorate was chosen from which one center was randomly selected. Quality of recorded data for each center in the central server (Data-oriented parameter), newly designed score to assess the overall performance of the centers was retrieved from computer based recording system. A self-administered questionnaire was completed by the centers head.
RESULTS: This study included 24 treatment centers from urban, rural areas, Upper and Lower Egypt. The Upper centers showed the best completeness of follow-up records and the least compliance rates. None of the centers had 100% completeness of follow-up data. Proportion of SVR is minimally less than proportion of patient with known outcome in all treatment centers. A novel indicator standardizing the comparisons of performance of different facilities was introduced: Total number of physicians/total number of SVR patients with completed records. The highest response rate: Monfiya Governorate (Lower Egypt), Aswan (Upper Egypt), Completeness of follow-up records: Kalyoubia (Lower Egypt), Sohag governorate (Upper Egypt). The average administrative score was 64%.
CONCLUSION: Challenges of NCCVH program: overcrowdings, resistant sociocultural background among rural patients, limited accessibility for internal migrants and incompleteness of data entry are system lacking points. Strengths include, clear patient pathway, well-established database online application, well-trained physicians and treatment availability.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Control of viral hepatitis; Facility performance; Hepatitis C virus; Treatment

Year:  2020        PMID: 32473817     DOI: 10.1016/j.jiph.2020.05.008

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  3 in total

1.  Schistosoma mansoni infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade.

Authors:  Hend Ibrahim Shousha; Ashraf Omar Abdelaziz; Mohamed Mahmoud Nabeel; Dalia Abdelhamid Omran; Ahmed Hosni Abdelmaksoud; Tamer Mahmoud Elbaz; Ayman Salah; Shady Tarek ElGhazaly Harb; Karim Adel Hosny; Ayman Osman; Mira Atef; Abdelazez Gaber; Naglaa Ali Zayed; Ayman Abdelhady Yosry; Rania Leithy
Journal:  Pathog Glob Health       Date:  2021-09-08       Impact factor: 3.735

2.  Egypt's Ambitious Strategy to Eliminate Hepatitis C Virus: A Case Study.

Authors:  Ahmed Hassanin; Serageldin Kamel; Iman Waked; Meredith Fort
Journal:  Glob Health Sci Pract       Date:  2021-03-31

3.  Three regimens for re-treatment failure of Sofosbuvir-based therapy for chronic hepatitis-C genotype-4: a cohort study.

Authors:  Hend Ibrahim Shousha; Reem Abdelghafour; Hosam Dabees; Wael AbdelRazek; Mohamed Said
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-09-05       Impact factor: 2.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.